LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways (Q38934314)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways |
scientific article |
Statements
1 reference
LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways (English)
1 reference
Youngro Byun
1 reference
Seung Woo Chung
1 reference
Sang Mun Bae
1 reference
Myungjin Lee
1 reference
Taslim A Al-Hilal
1 reference
Chang Kyung Lee
1 reference
Jeong Kon Kim
1 reference
In-San Kim
1 reference
Sang Yoon Kim
1 reference
28 October 2014
1 reference
1 reference
37
1 reference
271-278
1 reference
Identifiers
1 reference
1 reference